The RECHARGE Low Carbohydrate Diet Trial for Metastatic Cancer Read more about The RECHARGE Low Carbohydrate Diet Trial for Metastatic Cancer
A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage Read more about A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage
Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia Read more about Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia
Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer Read more about Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
Risk Stratification After Acute Myocardial Infarction With Cardiac MRI Read more about Risk Stratification After Acute Myocardial Infarction With Cardiac MRI
Safety, Clinical Activity, Pharmacokinetics (PK) and Pharmacodynamics Study of GSK2879552, Alone or With Azacitidine, in Subjects With High Risk Myelodysplastic Syndromes (MDS) Read more about Safety, Clinical Activity, Pharmacokinetics (PK) and Pharmacodynamics Study of GSK2879552, Alone or With Azacitidine, in Subjects With High Risk Myelodysplastic Syndromes (MDS)